🚀 VC round data is live in beta, check it out!

Stepan Valuation Multiples

Discover revenue and EBITDA valuation multiples for Stepan and similar public comparables like Elementis, Redox, Green Plains, LSB Industries and more.

Stepan Overview

About Stepan

Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.


Founded

1959

HQ

United States

Employees

2.4K

Website

stepan.com

Sectors

Financials (LTM)

Revenue: $2B
EBITDA: $212M

EV

$2B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Stepan Financials

Stepan reported last 12-month revenue of $2B and EBITDA of $212M.

In the same LTM period, Stepan generated $286M in gross profit, $212M in EBITDA, and $47M in net income.

Revenue (LTM)


Stepan P&L

In the most recent fiscal year, Stepan reported revenue of $2B and EBITDA of $212M.

Stepan is profitable as of last fiscal year, with gross margin of 12%, EBITDA margin of 9%, and net margin of 2%.

See analyst estimates for Stepan
LTMLast FY202320242025202620272028
Revenue$2B$2B$2B$2B$2B
Gross Profit$286M$270M$278M$272M$270M
Gross Margin12%12%12%12%12%
EBITDA$212M$212M$170M$192M$212M
EBITDA Margin9%9%7%9%9%
EBIT Margin4%3%3%3%3%
Net Profit$47M$47M$40M$50M$47M
Net Margin2%2%2%2%2%
Net Debt—$494M———

Financial data powered by Morningstar, Inc.

Stepan Stock Performance

Stepan has current market cap of $1B, and enterprise value of $2B.

Market Cap Evolution


Stepan's stock price is $51.59.

Stepan share price increased by 3.1% in the last 30 days, and decreased by 5.0% in the last year.

Stepan has an EPS (earnings per share) of $2.07.

See more trading valuation data for Stepan
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$1B3.1%3.1%1.4%-5.0%$2.07

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Stepan Valuation Multiples

Stepan trades at 0.7x EV/Revenue multiple, and 8.1x EV/EBITDA.

See NTM and 2027E valuation multiples for Stepan

EV / Revenue (LTM)


Stepan Financial Valuation Multiples

As of May 2, 2026, Stepan has market cap of $1B and EV of $2B.

Stepan has a P/E ratio of 25.0x.

LTMLast FY202320242025202620272028
EV/Revenue0.7x0.7x0.7x0.8x0.7x
EV/EBITDA8.1x8.1x10.1x8.9x8.1x
EV/EBIT19.6x24.7x23.5x24.2x24.7x
EV/Gross Profit6.0x6.4x6.2x6.3x6.4x
P/E25.0x25.0x29.1x23.2x25.0x
EV/FCF—67.6x(20.1x)43.6x67.6x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Stepan Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Stepan Margins & Growth Rates

In the most recent fiscal year, Stepan reported gross margin of 12%, EBITDA margin of 9%, and net margin of 2%.

See estimated margins and future growth rates for Stepan

Stepan Margins

Last FY20242025202720282029
Gross Margin12%12%12%
EBITDA Margin9%9%9%
EBIT Margin3%3%3%
Net Margin2%2%2%
FCF Margin1%2%1%

Stepan Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(6%)7%
Gross Profit Growth(2%)(1%)
EBITDA Growth13%10%
EBIT Growth(3%)(2%)
Net Profit Growth25%(7%)
FCF Growth(146%)(35%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Stepan Operational KPIs

Stepan's revenue per employee in the last FY averaged $1.0M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for Stepan
LTMLast FY202320242025202620272028
Rule of 4016%————
Bessemer Rule of X27%————
Revenue per Employee—$1.0M———
Opex per Employee—$0.1M———
S&M Expenses to Revenue2%2%2%2%2%
G&A Expenses to Revenue4%4%4%5%4%
R&D Expenses to Revenue3%3%3%3%3%
Opex to Revenue—9%9%9%9%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Stepan Competitors

Stepan competitors include Elementis, Redox, Green Plains, LSB Industries, São Martinho, Cosmo Advanced Materials, Petkim, CVR Partners, Braskem and Unipar.

Most Stepan public comparables operate across Chemicals.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Elementis2.3x2.2x9.0x8.9x
Redox1.4x1.3x13.7x13.1x
Green Plains0.7x0.7x18.3x12.4x
LSB Industries2.2x2.1x9.4x7.9x
São Martinho1.6x1.6x3.6x3.4x
Cosmo Advanced Materials4.5x4.1x104.6x83.3x
Petkim1.2x1.1x12.4x(97.0x)
CVR Partners3.0x3.0x8.5x—

This data is available for Pro users. Sign up to see all Stepan competitors and their valuation data.

Start Free Trial

Stepan M&A Activity

Stepan has acquired 2 companies to date.

Last acquisition by Stepan was on September 26th 2022. Stepan acquired PerformanX Specialty Chemicals for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Stepan

PerformanX Specialty Chemicals
Clariant
Description
PerformanX Specialty Chemicals manufactures anionic and nonionic surfactants, emulsifiers, and wetting agents for personal care, industrial cleaning, and agriculture applications. The Texas-based producer offers custom formulations with biodegradability profiles meeting EPA standards. Product lines include sulfate-free alternatives and high-foam concentrates for household detergents.
Clariant AG is a Switzerland-based specialty chemicals company with world-wide operations. The company reports in three business areas: care chemicals, absorbents and additives and catalysts. Care chemicals mainly targets consumer end markets such as personal care and homecare, but it also has an industrial component. Absorbents and additives encompass Clariant’s coatings and adhesives, absorbents, and plastics segments. Catalysts manufacturers process catalysts, mainly for petrochemical and syngas plants.
HQ CountryUnited StatesSwitzerland
HQ City
Columbus, OH
San Jose, CA
Deal Date26 Sep 202217 Sep 2020
Valuationundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Stepan acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Stepan

When was Stepan founded?Stepan was founded in 1959.
Where is Stepan headquartered?Stepan is headquartered in United States.
How many employees does Stepan have?As of today, Stepan has over 2K employees.
Who is the CEO of Stepan?Stepan's CEO is Luis E. Rojo.
Is Stepan publicly listed?Yes, Stepan is a public company listed on NYSE.
What is the stock symbol of Stepan?Stepan trades under SCL ticker.
When did Stepan go public?Stepan went public in 1972.
Who are competitors of Stepan?Stepan main competitors include Elementis, Redox, Green Plains, LSB Industries, São Martinho, Cosmo Advanced Materials, Petkim, CVR Partners, Braskem, Unipar.
What is the current market cap of Stepan?Stepan's current market cap is $1B.
What is the current revenue of Stepan?Stepan's last 12 months revenue is $2B.
What is the current revenue growth of Stepan?Stepan revenue growth (NTM/LTM) is 7%.
What is the current EV/Revenue multiple of Stepan?Current revenue multiple of Stepan is 0.7x.
Is Stepan profitable?Yes, Stepan is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Stepan?Stepan's last 12 months EBITDA is $212M.
What is Stepan's EBITDA margin?Stepan's last 12 months EBITDA margin is 9%.
What is the current EV/EBITDA multiple of Stepan?Current EBITDA multiple of Stepan is 8.1x.
How many companies Stepan has acquired to date?As of May 2026, Stepan has acquired 2 companies.
What was the largest acquisition by Stepan?None of the M&A deals Stepan has completed have disclosed valuations.
What companies Stepan acquired?Stepan acquired PerformanX Specialty Chemicals and Clariant.
In how many companies Stepan has invested to date?Stepan hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Stepan

Lists including Stepan

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial